A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: A randomised controlled study

Anaesthesia and Intensive Care

Volumn 41, Issue 6, 2013, Pages 719-727

  Alvarez, Julian ^a   Baluja, A ^a   Selas, S ^a   Otero, P ^a   Rial, M ^a   Veiras, S ^a   Caruezo, V ^a   Taboada, M ^a   Rodriguez, I ^a   Castroagudin, J ^a   Tome, S ^a   Rodriguez, A ^a   Rodriguez, J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cardiac surgery; Levosimendan; Liver circulation; Low cardiac output

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORWARD HEART FAILURE; HEART INDEX; HEART SURGERY; HEMODYNAMICS; HEPATIC ARTERY; HUMAN; LIVER BLOOD FLOW; MALE; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; SPLANCHNIC BLOOD FLOW; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; LIVER CIRCULATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE; DRUG EFFECTS;

CARDIAC SURGERY; LEVOSIMENDAN; LIVER CIRCULATION; LOW CARDIAC OUTPUT;

AGED; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; LIVER CIRCULATION; MALE; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; VASCULAR RESISTANCE;

EID: 84891872063     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100606     Document Type: Article

References (32)

1. Adluri RKP, Singh AV, Skoyles J, Robins A, Hitch A, Baker M, Mitchell IM. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 2009; 35:988-994.
2. Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulanos S. Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int 2007; 6:383-387.
3. Raman JS, Kochi K, Morimatsu H, Buxton B, Bellomo R. Severe ischemic early liver injury after cardiac surgery. Ann Thorac Surg 2002; 74:1601-1606.
4. Braun JP, Schroeder T, Buehner S, Dohmen P, Moshirzadeh M, Grosse J, Streit F, Schlaefke A, Armstrong VW, Oellerich M, Lochs H, Konertz W, Kox WJ, Spies C. Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2004; 48:697-703.
5. Straub U, Winning J, Greilach P, Isringhaus H, Kalweit G, Huwer H. Alterations of mesenteric blood flow after cardiopulmonary bypass: a Doppler sonographic study. J Cardiothorac Vasc Anesth 2004; 18:731-733.
6. Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006; 12:325-332.
7. Yuen VMY, Chow BFM, Irwin MG. Severe hypotension and hepatic dysfunction in a patient undergoing scoliosis surgery in the prone position. Anaesth Intensive Care 2005; 33:393-399.
8. Gatecel C, Losser MR, Payen D. The postoperative effects of halothane versus isoflurane on hepatic artery and portal vein blood flow in humans. Anesth Analg 2003; 96:740-745.
9. Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, Bedirli A, Ozlu O, Pasaoglu H. . Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg 2008; 106:830.
10. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery, a systematic literature review. Crit Care 2005; 9:266.
11. Álvarez J, Bouzada M, Fernández A, Caruezo V, Taboada M, Rodríguez J. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006; 59:338.
12. Soeding PE, Royse CF, Wright CE, Royse AG, Angus JA. Inoprotection: the perioperative role of levosimendan. Anaesth Intensive Care 2007; 35:845-862.
13. Alvarez J. Levosimendan and low cardiac output syndrome. Does mortality really decrease? Rev Esp Cardiol 2008; 61:454.
14. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104:556.
15. Landoni G, Mizzi A, Biondi-Zoccai G, Bignami E, Prati P, Ajello V. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiologica 2010; 76:276.
16. Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care 2011; 15:R140.
17. Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, Guarracino F, Zangrillo A. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med 2012; 40:634.
18. Wachsberg RH. B-flow imaging of the hepatic vasculature: correlation with color Doppler sonography. AJR Am J Roentgenol 2007; 188:W522-533.
19. Liu CH, Hsu SJ, Lin JW, Hwang JJ, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH, Chen DS. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Clin Gastroenterol Hepatol 2007; 5:1199-1206.e1.
20. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229:409-414.
21. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004; 84:355-373.
22. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et at. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14:803-869.
23. Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102:198-204.
24. Richards ER, Kabir SI, McNaught C-E, MacFie J. Effect of thoracic epidural anaesthesia on splanchnic blood flow. Br J Surg 2013; 100:316-321.
25. Pannen Benedikt HJ. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 2002; 94:1448-1457.
26. Browse DJ, Mathie RT, Benjamin IS, Alexander B. The role of ATP and adenosine in the control of hepatic blood flow in the rabbit liver in vivo. Comp Hepatol 2003; 2:9.
27. Adluri RKP, Singh AV, Skoyles J, Robins A, Hitch A, Baker M, Mitchell IM. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 2009; 35:988-994.
28. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 2008; 147:153-159.
29. Iijima T, Ohishi F, Tatara T, Iwao Y. Effect of continuous infusion of prostaglandin E1 on hepatic blood flow. J Clin Anesth 2001; 13:250-254.
30. Leppikangas H, Jarvela K, Sisto T, Maaranen P, Virtanen M, Lehto P, Karlsson S, Koobi T, Lindgren L. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 2011; 106:298-304.
31. Garcia-Septien J, Lorente JA, Delgado MA, de Paula M, Nin N, Moscoso A, Sanchez-Ferrer A, Perez-Vizcaino F, Esteban A. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock. Shock 2010; 34:275-280.
32. Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16:6046-6057.